Press release
Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Trends and Forecast Report 2022 | By Players, Types, Applications and Regions
QY Research released a latest market research report on the global and United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.Summary
Due to the COVID-19 pandemic, the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, 25 ml accounting for % of the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hopistial was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Scope and Market Size
Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market size by players, by Color and by Sales Channels, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
For More Information About This Report, Please Enter:
https://us.qyresearch.com/reports/352524/cytomegalovirus-immune-globulin-intravenous-human-cmv-igiv
Segment by Type
25 ml
50 ml
100 ml
Segment by Application
Hopistial
Clinic
Others
By Company
CSL
Biotest
Beijing Tiantan Biological Products
Taibang Biologic Group
Shanxi Kangbao Biological Product
The report on the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market covers the following region (country) analysis:
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Goal of the Report
1.To study and analyze the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
2.To understand the structure of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)market by identifying its various subsegments.
3.Focuses on the key global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
4.To analyze the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)with respect to individual growth trends, prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
6.To project the consumption of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Target Audience
> Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) companies
> Research organizations
> Government Organizations
> Research/Consultancy firms
Table of Contents
1 Study Coverage
1.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Introduction
1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume for the Year 2017-2028
1.3 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume for the Year 2017-2028
1.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Dynamics
1.5.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Trends
1.5.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Drivers
1.5.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Challenges
1.5.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Segment by Type
2.1.1 25 ml
2.1.2 50 ml
2.1.3 100 ml
2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type
2.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Type
2.3.1 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Segment by Application
3.1.1 Hopistial
3.1.2 Clinic
3.1.3 Others
3.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application
3.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Application
3.3.1 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Competitor Landscape by Company
4.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Company
4.1.1 Top Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Manufacturer (2017-2022)
4.1.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Manufacturer (2017-2022)
4.1.4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Manufacturer (2017-2022)
4.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Concentration Ratio (CR)
4.2.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) in 2021
4.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturing Base Distribution, Product Type
4.3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Type
4.3.3 Date of International Manufacturers Enter into Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Company
4.5.1 Top Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Players (2020, 2021 & 2022)
5 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Region
5.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size in Volume by Region (2017-2028)
5.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume by Region: 2017-2022
5.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size in Value by Region (2017-2028)
5.3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Value by Region: 2017-2022
5.3.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size YoY Growth 2017-2028
6.1.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size YoY Growth 2017-2028
6.3.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size YoY Growth 2017-2028
6.4.2 Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 CSL
7.1.1 CSL Corporation Information
7.1.2 CSL Description and Business Overview
7.1.3 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Products Offered
7.1.5 CSL Recent Development
7.2 Biotest
7.2.1 Biotest Corporation Information
7.2.2 Biotest Description and Business Overview
7.2.3 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Products Offered
7.2.5 Biotest Recent Development
7.3 Beijing Tiantan Biological Products
7.3.1 Beijing Tiantan Biological Products Corporation Information
7.3.2 Beijing Tiantan Biological Products Description and Business Overview
7.3.3 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Products Offered
7.3.5 Beijing Tiantan Biological Products Recent Development
7.4 Taibang Biologic Group
7.4.1 Taibang Biologic Group Corporation Information
7.4.2 Taibang Biologic Group Description and Business Overview
7.4.3 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Products Offered
7.4.5 Taibang Biologic Group Recent Development
7.5 Shanxi Kangbao Biological Product
7.5.1 Shanxi Kangbao Biological Product Corporation Information
7.5.2 Shanxi Kangbao Biological Product Description and Business Overview
7.5.3 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Products Offered
7.5.5 Shanxi Kangbao Biological Product Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Chain Analysis
8.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Distributors
8.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Production Mode & Process
8.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales and Marketing
8.4.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Channels
8.4.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Distributors
8.5 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click:
https://us.qyresearch.com/reports/352524/cytomegalovirus-immune-globulin-intravenous-human-cmv-igiv
Any doubts and questions will be welcome.
Customization of the Report:
This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
QY Research released a latest market research report on the global and United States Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Trends and Forecast Report 2022 | By Players, Types, Applications and Regions here
News-ID: 2629308 • Views: …
More Releases from QY Research
Global and U.S. Precision Micro Stamping Presses Market Report, Published by QY …
Precision Micro Stamping Presses are high-accuracy mechanical or servo-driven machines designed to fabricate miniature metal components with micron-level tolerances. These presses perform high-speed stamping, coining, and forming of micro parts used in electronics, medical devices, automotive sensors, and aerospace systems. By combining precision tooling, feedback control, and vibration-free actuation, they enable mass production of complex microstructures in thin metals such as copper, stainless steel, titanium, and nickel alloys.
https://www.qyresearch.com/reports/4709777/precision-micro-stamping-presses
Core market data:
Global…
Nebulizer Medicine Cup Market to Reach USD 951 Million by 2031 Top 20 Company Gl …
The nebulizer medicine cup is the small but mission-critical consumable that holds liquid medication for aerosolization in jet, ultrasonic and mesh nebulizer systems; it is manufactured as a regulated single-use or reusable plastic assembly and sits at the intersection of precision medical plastics, assembly/sterilization processes, and pharmaceutical drug-delivery protocols. This sub-segment supports hospitals, long-term care, outpatient clinics, and the growing home-care and pharmaceutical OEM markets by enabling accurate dose delivery,…
Freezing Point IPL Hair Removal Device Market to Reach USD 21,710 Million by 203 …
The Freezing Point IPL hair removal device category is a sub-segment of the broader IPL/at-home and professional light-based hair removal market that differentiates itself by integrating active cooling or freezing point skin-contact surfaces (sapphire/ceramic cooling plates, thermoelectric modules or circulating coolant) to reduce treatment pain and permit higher energy settings. These devices range from low-cost handheld consumer models to integrated multi-handpiece professional platforms sold to clinics and beauty chains. The…
Belay Glasses for Rock Climbing Market to Reach USD 152 Million by 2031 Top 10 C …
Belay glasses are specialized prismatic eyewear that let a belayer watch a climber high on a wall without repeatedly tilting their head upward, reducing neck strain and improving attentiveness during long sessions. The product category ranges from low-cost clip-on prism inserts to premium adjustable-angle frames with BK7 optical prisms; the market serves recreational climbers, indoor climbing gyms, guiding services, and safety-conscious outdoor climbers. Adoption has been driven by the growth…
More Releases for Cytomegalovirus
Cytomegalovirus (CMV) Infections Market Massive Growth opportunity Ahead
Introduction
Cytomegalovirus (CMV) is a common herpesvirus that affects people worldwide, often remaining latent in the body and reactivating under immunocompromised conditions. While typically asymptomatic in healthy individuals, CMV can cause severe complications in newborns, transplant recipients, and immunocompromised patients, making it a significant global healthcare burden.
With increasing awareness, advances in antiviral therapies, vaccines under development, and transplant-related CMV management, the CMV infections market is experiencing strong growth. The integration of…
Cytomegalovirus Retinitis Market Forecast 2031: Growth and Opportunities
The "Cytomegalovirus Retinitis Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside…
Cytomegalovirus Solutions Soar: Cytomegalovirus Treatment Market Targets US$ 326 …
The Cytomegalovirus (CMV) Treatment Market stands at the forefront of addressing a formidable viral adversary that often operates under the radar. Cytomegalovirus, a member of the herpesvirus family, can pose serious threats to individuals with weakened immune systems, such as transplant recipients and those living with HIV. As a result, the development of effective treatments has become a critical endeavor in the realm of infectious diseases.
In 2022, the global cytomegalovirus…
Cytomegalovirus Treatment Market Will Generate Record Revenue by 2029
The global cytomegalovirus treatment market is anticipated to grow at a CAGR of 30.1% during the forecast period (2023-2030). Cytomegalovirus is one of the most common and serious post-transplant infections and can lead to loss of transplanted organ and failure of graft. It has a global estimated incidence rate of 16.0%-56.0% in SOT recipients and 30.0%-70.0% in HSCT recipients.More than 34,000 SOTs and more than 48,000 HSCTs were performed in…
Cytomegalovirus Diagnostics Market Research Insights, Trends Forecast 2022-28
The global cytomegalovirus diagnostics market size was valued at USD 73.6 million in 2021, growing at a CAGR of 6.1% during the forecast period 2022-28. A common herpesvirus called cytomegalovirus can produce a wide range of symptoms, from little to no symptoms to fever and tiredness to severe symptoms affecting the brain, eyes, and other internal organs. Plasma, sperm, saliva, urinalysis, and breast milk can all be used as…
Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many…
